Recap: Marsh & McLennan Q1 Earnings

Marsh & McLennan (NYSE:MMC) reported its Q1 earnings results on Thursday, April 20, 2023 at 07:00 AM. Here’s…

Marsh & McLennan (NYSE:MMC) reported its Q1 earnings results on Thursday, April 20, 2023 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Marsh & McLennan beat estimated earnings by 2.43%, reporting an EPS of $2.53 versus an estimate of $2.47.

Revenue was up $375.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06 which was followed by a 2.01% drop in the share price the next day.

Here’s a look at Marsh & McLennan’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 1.41 1.15 1.87 2.14
EPS Actual 1.47 1.18 1.89 2.30
Revenue Estimate 5.20B 4.85B 5.33B 5.50B
Revenue Actual 5.02B 4.77B 5.38B 5.55B

To track all earnings releases for Marsh & McLennan visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The One Month Ended May 2023, And Year-To-Date May 2023, Based On Currently Available Information; May 23 Net Sales $4.2M-$5.1M

Scilex Holding Company (NASDAQ:SCLX, ", Scilex", )))), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC:SRNEQ), an innovative revenue-generating company focused on acquiring, developing and

SCLX